Essilorluxottica (ESLOY)
113.37
+1.48
(+1.32%)
USD |
OTCM |
May 17, 16:00
Essilorluxottica Debt to Equity Ratio: 0.2201 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2201 |
| June 30, 2023 | 0.2272 |
| December 31, 2022 | 0.2409 |
| June 30, 2022 | 0.2909 |
| December 31, 2021 | 0.2838 |
| June 30, 2021 | 0.2823 |
| December 31, 2020 | 0.3086 |
| June 30, 2020 | 0.3038 |
| December 31, 2019 | 0.2088 |
| June 30, 2019 | 0.1289 |
| December 31, 2018 | 0.1137 |
| June 30, 2018 | 0.3822 |
| December 31, 2017 | 0.3213 |
| June 30, 2017 | 0.4538 |
| December 31, 2016 | 0.3903 |
| Date | Value |
|---|---|
| June 30, 2016 | 0.445 |
| December 31, 2015 | 0.4519 |
| June 30, 2015 | 0.5109 |
| December 31, 2014 | 0.4979 |
| June 30, 2014 | 0.6507 |
| December 31, 2013 | 0.3126 |
| June 30, 2013 | 0.2662 |
| December 31, 2012 | 0.2501 |
| June 30, 2012 | 0.3439 |
| December 31, 2011 | 0.2754 |
| June 30, 2011 | 0.3061 |
| December 31, 2010 | 0.2294 |
| June 30, 2010 | 0.343 |
| December 31, 2009 | 0.1344 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1289
Minimum
Jun 2019
0.3086
Maximum
Dec 2020
0.2495
Average
0.2616
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.3968 |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 0.9462 |
| Innate Pharma SA | 0.7525 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 66.90B |
| Total Liabilities (Quarterly) | 23.91B |
| Shareholders Equity (Quarterly) | 42.27B |
| Current Ratio | 0.9979 |
| Net Debt Paydown Yield | 0.80% |